Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17227438rdf:typepubmed:Citationlld:pubmed
pubmed-article:17227438lifeskim:mentionsumls-concept:C0028040lld:lifeskim
pubmed-article:17227438lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:17227438lifeskim:mentionsumls-concept:C1704666lld:lifeskim
pubmed-article:17227438lifeskim:mentionsumls-concept:C1517892lld:lifeskim
pubmed-article:17227438lifeskim:mentionsumls-concept:C1883709lld:lifeskim
pubmed-article:17227438lifeskim:mentionsumls-concept:C0208973lld:lifeskim
pubmed-article:17227438pubmed:issue1lld:pubmed
pubmed-article:17227438pubmed:dateCreated2007-1-17lld:pubmed
pubmed-article:17227438pubmed:abstractTextEpidemiological studies indicate that smoking is a negative, and exposure to pesticides, a positive risk factor for Parkinson's disease (PD). The purpose of this study was to assess the interplay between these two factors in a rodent model of nigrostriatal damage. To approach this, mice were administered nicotine, the agent in smoke implicated in neuroprotection. They were then treated for 3 weeks with the pesticide, paraquat, while nicotine was continued. Paraquat treatment decreased (25%) nigral dopaminergic neurons, consistent with previous results. Chronic nicotine administration significantly protected against nigral cell damage, with only a 16% decline in mice treated with both nicotine and paraquat. Paraquat treatment also decreased (14%) the striatal dopamine transporter, an effect that was partially prevented by nicotine. These changes in the striatal dopamine transporter paralleled those in a select striatal alpha6beta2* nicotinic receptor (nAChR) subtype. In contrast, striatal alpha4beta2* nAChRs were not decreased with paraquat treatment, suggesting they are on a differential subset of dopaminergic terminals. The results show that nicotine treatment partially protects against paraquat-induced declines in nigrostriatal dopaminergic neurons to which a select population of alpha6beta2* nAChRs are localized. Moreover, these data support epidemiological findings that environmental influences can elicit opposing effects on nigrostriatal dopaminergic integrity.lld:pubmed
pubmed-article:17227438pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17227438pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17227438pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17227438pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17227438pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17227438pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17227438pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17227438pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17227438pubmed:languageenglld:pubmed
pubmed-article:17227438pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17227438pubmed:citationSubsetIMlld:pubmed
pubmed-article:17227438pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17227438pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17227438pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17227438pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17227438pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17227438pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17227438pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17227438pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17227438pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17227438pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17227438pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17227438pubmed:statusMEDLINElld:pubmed
pubmed-article:17227438pubmed:monthJanlld:pubmed
pubmed-article:17227438pubmed:issn0022-3042lld:pubmed
pubmed-article:17227438pubmed:authorpubmed-author:Di...lld:pubmed
pubmed-article:17227438pubmed:authorpubmed-author:McIntoshJ...lld:pubmed
pubmed-article:17227438pubmed:authorpubmed-author:QuikMarykaMlld:pubmed
pubmed-article:17227438pubmed:authorpubmed-author:McCormackAlis...lld:pubmed
pubmed-article:17227438pubmed:authorpubmed-author:KhwajaMiriumMlld:pubmed
pubmed-article:17227438pubmed:issnTypePrintlld:pubmed
pubmed-article:17227438pubmed:volume100lld:pubmed
pubmed-article:17227438pubmed:ownerNLMlld:pubmed
pubmed-article:17227438pubmed:authorsCompleteYlld:pubmed
pubmed-article:17227438pubmed:pagination180-90lld:pubmed
pubmed-article:17227438pubmed:dateRevised2011-9-22lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:meshHeadingpubmed-meshheading:17227438...lld:pubmed
pubmed-article:17227438pubmed:year2007lld:pubmed
pubmed-article:17227438pubmed:articleTitleNicotine partially protects against paraquat-induced nigrostriatal damage in mice; link to alpha6beta2* nAChRs.lld:pubmed
pubmed-article:17227438pubmed:affiliationThe Parkinson's Institute, Sunnyvale, CA 94089, USA.lld:pubmed
pubmed-article:17227438pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17227438pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17227438lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17227438lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17227438lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17227438lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17227438lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17227438lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17227438lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17227438lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17227438lld:pubmed